Subscribe to RSS
DOI: 10.1055/s-0042-1744421
Plastic Surgeons as Medical Directors: A Natural Transition into Medical Leadership
Abstract
With the growing complexity of the U.S. health care system, highly motivated medical directors with strong leadership skills are vital to the success of health care facilities. Presently, there are no articles assessing a plastic surgeon's qualifications for the role of medical director. In addition, there is a paucity of literature comparing the responsibilities of medical directors across various types of health care institutions. Herein, we outline why plastic surgeons have the unique skillset to succeed in this role and highlight the differences between medical director positions across the vast landscape of health care. While the intricacies of this position vary greatly across different landscapes of the health care industry, successful medical directors lead by following a set of universal principles predisposing them for success. Plastic surgeons innately exhibit a subset of particular traits deeming them suitable candidates for the medical director position. While transitioning from the role of a surgeon to that of a medical director does require some show of adaptation, plastic surgeons are ultimately highly likely to find intrinsic benefit from serving as a medical director.
Author Contributions
Conceptualization: A.M.F., A.C., E.M.R., S.A.I., V.J.H., Y.T., E.P.B., S.J.W. Methodology: F.J. Visualization: F.J., A.M.F., A.C., E.M.R., S.A.I., V.J.H., Y.T., E.P.B., S.J.W. Writing - original draft: F.J., A.M.F., A.C., S.J.W. Writing - review & editing: F.J., A.M.F., A.C., E.M.R., S.A.I., V.J.H., Y.T., E.P.B., S.J.W.
Publication History
Article published online:
06 April 2022
© 2022. The Korean Society of Plastic and Reconstructive Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Weber DO. Physicians lead the way at America's top hospitals. Physician Exec 2001; 27 (03) 24-29
- 2 Fielden J. A medical director's perspective on healthcare leadership. Future Hosp J 2015; 2 (03) 190-193
- 3 Clay-Williams R, Ludlow K, Testa L, Li Z, Braithwaite J. Medical leadership, a systematic narrative review: do hospitals and healthcare organisations perform better when led by doctors?. BMJ Open 2017; 7 (09) e014474
- 4 Weintraub P, McKee M. Leadership for innovation in healthcare: an exploration. Int J Health Policy Manag 2019; 8 (03) 138-144
- 5 Belrhiti Z, Nebot Giralt A, Marchal B. Complex leadership in healthcare: a scoping review. Int J Health Policy Manag 2018; 7 (12) 1073-1084
- 6 Cutter TW. The role of the medical director. Ambul Surg 2005; 12: 7-9
- 7 Taylor CA, Taylor JC, Stoller JK. Exploring leadership competencies in established and aspiring physician leaders: an interview-based study. J Gen Intern Med 2008; 23 (06) 748-754
- 8 Johnston IH. What will the medical director do?. BMJ 1991; 302 (6771): 280-281
- 9 Saha S, Wish JB. Leading the dialysis unit: role of the medical director. Adv Chronic Kidney Dis 2018; 25 (06) 499-504
- 10 Eagle C. Physicians at the executive table. Healthc Manage Forum 2016; 29 (01) 15-18
- 11 Verheyden CN, Levin LS. Plastic surgery leadership in an institution: a primer. Plast Reconstr Surg 2010; 125 (06) 1819-1825
- 12 Addona T, Polcino M, Silver L, Taub PJ. Leadership trends in plastic surgery. Plast Reconstr Surg 2009; 123 (02) 750-753
- 13 Neumeister MW. Can a plastic surgeon be a department chairman?….really?. Handchir Mikrochir Plast Chir 2016; 48 (02) 69-72
- 14 Pu LL, Mirmanesh M. The role of plastic surgery at an academic medical center in the United States. Ann Plast Surg 2017; 78 (05) 481-486
- 15 Lowe G. How employee engagement matters for hospital performance. Healthc Q 2012; 15 (02) 29-39
- 16 Kossaify A, Rasputin B, Lahoud JC. The function of a medical director in healthcare institutions: a master or a servant. Health Serv Insights 2013; 6: 105-110
- 17 Dixon-Woods M, McNicol S, Martin G. Ten challenges in improving quality in healthcare: lessons from the Health Foundation's programme evaluations and relevant literature. BMJ Qual Saf 2012; 21 (10) 876-884
- 18 Merrill DG. Practice management/role of the medical director. Anesthesiol Clin 2014; 32 (02) 529-540
- 19 Giancotti M, Guglielmo A, Mauro M. Efficiency and optimal size of hospitals: Results of a systematic search. PLoS One 2017; 12 (03) e0174533
- 20 Scuffham PA, Devlin NJ, Jaforullah M. The structure of costs and production in New Zealand public hospitals: an application of the transcendental logarithmic variable cost function. Appl Econ 1996; 28: 75-85
- 21 Vargas HD. Private practice for the colon and rectal surgeon. Clin Colon Rectal Surg 2006; 19 (03) 119-128
- 22 Gabel S. The relationship between the medical director and the executive director: guidelines for success. Psychiatr Q 2011; 82 (01) 23-31
- 23 Pawlecki JB, Burton WN, Christensen C. et al; ACOEM Corporate Medical Directors Section Task Force. Role and value of the corporate medical director. J Occup Environ Med 2018; 60 (05) e215-e226
- 24 Baines R, Regan de Bere S, Stevens S. et al. The impact of patient feedback on the medical performance of qualified doctors: a systematic review. BMC Med Educ 2018; 18 (01) 173
- 25 Sullivan C, Murano T, Comes J, Smith JL, Katz ED. Emergency medicine directors' perceptions on professionalism: a Council of Emergency Medicine Residency Directors survey. Acad Emerg Med 2011; 18 (Suppl. 02) S97-S103
- 26 Medical errors: focusing more on what and why, less on who. J Oncol Pract 2007; 3 (02) 66-70
- 27 Davies H, Powell A, Rushmer R. Why don't clinicians engage with quality improvement?. J Health Serv Res Policy 2007; 12 (03) 129-130
- 28 Taitz JM, Lee TH, Sequist TD. A framework for engaging physicians in quality and safety. BMJ Qual Saf 2012; 21 (09) 722-728
- 29 Jeve YB, Oppenheimer C, Konje J. Employee engagement within the NHS: a cross-sectional study. Int J Health Policy Manag 2015; 4 (02) 85-90
- 30 Jahromi VK, Tabatabaee SS, Abdar ZE, Rajabi M. Active listening: The key of successful communication in hospital managers. Electron Physician 2016; 8 (03) 2123-2128
- 31 Forster AJ, Turnbull J, McGuire S, Ho ML, Worthington JR. Improving patient safety and physician accountability using the hospital credentialing process. Open Med 2011; 5 (02) e79-e86
- 32 Shaikh A, AlTurabi L, West Jr DJ. Developing a successful master of health administration student mentor-mentee program. Health Care Manag (Frederick) 2016; 35 (01) 47-57
- 33 Silva PJ, Ramos KS. Academic medical centers as innovation ecosystems: evolution of industry partnership models beyond the Bayh-Dole Act. Acad Med 2018; 93 (08) 1135-1141
- 34 Gottlieb M, Lee S, Burkhardt J. et al. Show me the money: successfully obtaining grant funding in medical education. West J Emerg Med 2019; 20 (01) 71-77
- 35 McKiernan EC, Bourne PE, Brown CT. et al. How open science helps researchers succeed. eLife 2016; 5: e16800
- 36 Levinson MJ, Musher J. Current role of the medical director in community-based nursing facilities. Clin Geriatr Med 1995; 11 (03) 343-358
- 37 Stein D, Chen C, Ackerly DC. Disruptive innovation in academic medical centers: balancing accountable and academic care. Acad Med 2015; 90 (05) 594-598
- 38 Ebadi A, Schiffauerova A. How to receive more funding for your research? Get connected to the right people!. PLoS One 2015; 10 (07) e0133061
- 39 Monte AA, Libby AM. Introduction to the specific aims page of a grant proposal. Acad Emerg Med 2018; 25 (09) 1042-1047
- 40 Lehoux P, Miller FA, Daudelin G. How does venture capital operate in medical innovation?. BMJ Innov 2016; 2 (03) 111-117
- 41 Leytes LJ. Raising venture capital in the biopharma industry. Drug Discov Today 2002; 7 (22) 1125-1127
- 42 Goddard M. Competition in healthcare: good, bad or ugly?. Int J Health Policy Manag 2015; 4 (09) 567-569
- 43 Collins-Nakai R. Leadership in medicine. McGill J Med 2006; 9 (01) 68-73
- 44 Porter ME. Industry structure and competitive strategy: keys to profitability. Financ Anal J 1980; 36: 30-41
- 45 Kettelhut MC. Strategic requirements for IS in the turbulent healthcare environment. J Syst Manag 1992; 43: 6-9
- 46 Lazarus A. The human factor in mergers and acquisitions: a personal story. Psychiatr Serv 2000; 51 (01) 19-20
- 47 Harvin A, Griffith N, Weber RJ. Physicians as executives: opportunities and strategies for health-system pharmacy leaders. Hosp Pharm 2014; 49 (10) 985-991
- 48 Gagnon MA, Volesky KD. Merger mania: mergers and acquisitions in the generic drug sector from 1995 to 2016. Global Health 2017; 13 (01) 62
- 49 Sawyer NT. In the U.S. “healthcare” is now strictly a business term. West J Emerg Med 2018; 19 (03) 494-495
- 50 Parekh SG, Singh B. An MBA: the utility and effect on physicians' careers. J Bone Joint Surg Am 2007; 89 (02) 442-447
- 51 Turner AD, Stawicki SP, Guo WA. Competitive advantage of MBA for physician executives: a systematic literature review. World J Surg 2018; 42 (06) 1655-1665
- 52 Harolds JA. Tips for leaders, part II: leading a private practice physician group. Clin Nucl Med 2011; 36 (09) 786-787
- 53 Shah ED, Allen JI. How to become a physician executive: from fellowship to leadership. Gastroenterology 2018; 154 (04) 784-787
- 54 Maykel JA. Leadership in surgery. Clin Colon Rectal Surg 2013; 26 (04) 254-258
- 55 Elon R. The nursing home medical director role in transition. J Am Geriatr Soc 1993; 41 (02) 131-135
- 56 Katz P, Karuza J, Parker M. A national survey of nursing home medical directors. J Med Dir 1992; 1: 81-94
- 57 Jones ER, Goldman RS. Managing disruptive behavior by patients and physicians: a responsibility of the dialysis facility medical director. Clin J Am Soc Nephrol 2015; 10 (08) 1470-1475
- 58 Anderson TS, Dave S, Good CB, Gellad WF. Academic medical center leadership on pharmaceutical company boards of directors. JAMA 2014; 311 (13) 1353-1355